Latest news
Cyclerion Therapeutics (CYCN) outlines terms, risks and disclosures for proposed Korsana merger - Stock TitanStock Titan · Fri, 07 Aug 2026 02:37:28 GMTCyclerion Therapeutics (NASDAQ: CYCN) outlines Korsana merger and going concern risk - Stock TitanStock Titan · Tue, 04 Aug 2026 20:16:39 GMTCyclerion (CYCN) and Korsana add leaders as reverse merger targets Q3 2026 close - Stock TitanStock Titan · Mon, 03 Aug 2026 21:14:31 GMTKorsana Biosciences Appoints Matthew Leoni, M.D., Gan Wei, Ph.D., and Heidi Henson as Company Advances Alzheimer’s Program - citybizcitybiz · Mon, 03 Aug 2026 12:35:31 GMTKorsana Biosciences Strengthens Leadership with Executive and Board Appointments to Support Next Phase of Growth - Business WireBusiness Wire · Mon, 03 Aug 2026 11:00:00 GMT